(Press-News.org) Athens, 18 May 2014: Heart failure hospitalisation more than doubles during inflammatory bowel disease (IBD) flares, according to a study of more than 5 million Danish people. The research was presented today at the Heart Failure Congress 2014, held 17-20 May, in Athens, Greece. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology.
Dr Søren L. Kristensen, lead author, said: "Previous studies have shown an association between chronic inflammatory diseases (psoriasis, rheumatoid arthritis, systemic lupus erythematosus, celiac disease and IBD) and an increased incidence of venous- and arterial thrombotic disease (primarily heart attack and stroke). Researchers suggest the link is at least in part caused by inflammatory prothrombotic effects."
He added: "However not many studies have investigated whether the risk of heart failure is elevated in patients with these inflammatory diseases, and none at all in patients with IBD. In the present study we aimed to clarify whether IBD patients had an increased risk of heart failure, and secondly whether this risk was correlated to periods of activity or 'flares' in the IBD."
The researchers used a nationwide cohort of 5 436 647 Danish citizens aged 18 years and above with no history of IBD or heart failure. In this study IBD was defined as Crohn's disease and ulcerative colitis. During 1997 to 2011, IBD developed in 23 681 patients, of whom 553 were hospitalised with heart failure during follow-up. Rates of hospitalisation for heart failure were compared between the IBD group and the remaining Danish population, adjusted for age and sex differences.
In patients with new-onset IBD, disease activity (flare, persistent activity, remission) was monitored continuously throughout the study and determined by hospitalisations and prescriptions of glucocorticoids. Flares were defined as a prescription or hospitalisation following a quiescent period. Persistent activity was defined as repeated prescriptions or hospitalisations.
Dr Kristensen said: "We found that patients with new-onset IBD had a 37% increased risk of hospitalisation for heart failure during a mean follow-up of 6.4 years compared to the healthy population. But the risk more than doubled during periods of IBD activity."
He added: "When IBD patients had flares their risk of hospitalisation for heart failure was 2.5 times greater, and it was 2.7 times greater during persistent activity. There was no increased risk during the quiescent stages of IBD. Our findings suggest that efficient IBD treatment aimed at reducing the length and number of disease activity episodes might lower the risk of heart failure."
Dr Kristensen continued: "We found an increased risk of hospitalisation for heart failure in IBD patients of all ages, not just older patients. Gastroenterologists and other health professionals need to be aware of the increased risk of cardiovascular diseases, including heart failure, in their daily handling of patients with IBD. It's also important that they don't neglect younger patients, who are also at cardiovascular risk."
IBD is known to have effects in the body beyond the intestine including anaemia, and musculoskeletal, dermatologic, hepatic and ocular complications. Dr Kristensen said: "Our results indicate that heart failure may need to be added to this list, and hence be considered when assessing these patients. Detecting heart failure early is crucial to halting its progression and improving prognosis."
Biological anti-inflammatory treatments offer the possibility of longer term remission to patients with IBD. Dr Kristensen said: "It will be interesting to see if these medications, which are increasingly used in IBD, lead to a reduction in the risk of heart failure and other cardiovascular diseases. We will investigate this question in a future observational study of all IBD patients in Denmark who are taking biological treatments."
He continued: "We cannot rule out the possibility that glucocorticoids used to manage IBD contribute to the risk of heart failure."
Dr Kristensen concluded: "There have been calls for patients hospitalised with IBD flares to receive thromboprophylaxis but such a general strategy needs more clinical validation. What is required is cardiovascular risk assessment of these patients, especially during IBD flares, so that heart failure and other cardiovascular complications can be detected early and treated appropriately."
INFORMATION:
References
Please see the details of the session here: http://spo.escardio.org/SessionDetails.aspx?eevtid=68&sessId=13641#.U2tDpP1XKC4
The abstract can be found in the press kit on site or should be requested at press@escardio.org
Notes to editor
About the European Society of Cardiology
The European Society of Cardiology (ESC) represents more than 80 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
About the Heart Failure Association (HFA)
The Heart Failure Association (HFA) is a registered branch of the ESC. Its aim is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
For practical information about heart failure aimed at patients, families and caregivers, visit the HFA's Heart Failure Matters website.
Did you want to tweet about our congress? - if you do, please use the official #heartfailure2014 hashtag! Thank you
Information for journalists attending Heart Failure 2014
If you have any question or request regarding interview opportunities, please contact:
ESC Press Office
Jacqueline Partarrieu
press@escardio.org
Tel: +33 6 22 83 45 76 (off site support number)
Heart Failure 2014 takes place in Athens, Greece, on 17-20 May 2014 at the MAICC Congress Center.
Look here for the current final programme:
http://www.escardio.org/congresses/heart-failure-2014/Documents/fp-hf2014-web.pdf?hit=highlight-on
For full details of a session, have a look at the Scientific Programme & Planner:
http://spo.escardio.org/default.aspx?eevtid=68&showResults=False
On-site Press registration process:
Free registration applies to press representatives upon receipt of valid credentials and a fully completed embargo form.
Credential: either your ID press card or letter of assignment with proof of 3 published articles
Press registration is not available to Industry or its Public Relations representatives, event management, marketing or communications representatives
The decision of the ESC Press Office is final regarding all press registration requests.
When your registration as press will be validated you will be given a press badge and the press kit.
The press working area is located in front of the registration desks. It features free wifi and a printer linked to a computer.
Heart failure hospitalization more than doubles in IBD flares
2014-05-18
ELSE PRESS RELEASES FROM THIS DATE:
Beyond GDP: Birth weight, hours slept, eyeglasses among innovative yardsticks of well-being, wealth
2014-05-18
Birth weight, hours slept, eyeglasses, city birds, washing machines, teenage schoolgirls and other quantifiable signals of well-being can help measure the wealth of a nation beyond Gross Domestic Product, experts say.
Moving beyond GDP to sustainability — the focus of a UN-backed high-level symposium May 19 in Kuala Lumpur, Malaysia — requires broad indicators of a nation's social and environmental well-being to complement measures of economic production and income.
"World leaders are acknowledging GDP's limitations, as well as the need for broader measures to evaluate ...
PARADIGM-HF trial stopped early for benefit
2014-05-18
p>Athens, 16 May 2014: The PARADIGM-HF trial has been stopped early for a benefit to patients that was overwhelmingly statistically significant. In the largest ever study of a heart failure treatment, LCZ696 won a head to head comparison with gold standard treatment and improved the primary composite endpoint of cardiovascular death or heart failure hospitalisation, and reduced cardiovascular mortality alone.
The latest update on the trial, describing the design and baseline characteristics of patients, was presented today at the Heart Failure Congress 2014 by Professor ...
Clinicians urged to consider spironolactone in HFPEF despite TOPCAT results
2014-05-18
Athens, 18 May 2014: Clinicians have been urged to consider using spironolactone in their patients with heart failure and preserved ejection fraction (HFPEF) after a post-hoc analysis of the TOPCAT trial showed benefit in patients from the Americas.
The research was presented today at the Heart Failure Congress 2014 in Athens, Greece. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology.
Professor Bertram Pitt said: "We've had many studies showing that ACE inhibitors, angiotensin receptor blockers, beta blockers ...
Cardiovascular diseases rise during Greek financial crisis
2014-05-18
Athens, 18 May 2014: Hospital admissions for cardiovascular diseases increased during the Greek financial crisis, according to two studies from Athens. The research was presented today at the Heart Failure Congress 2014, held 17-20 May in Athens, Greece. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology.
Dr Alexios Samentzas said: "Greece plunged into an economic crisis in 2008 and since then there have been rises in unemployment, wage reductions and a fall in standard of living. Previous studies have shown ...
Most emergency department 'super-frequent users' have a substance abuse addiction
2014-05-17
DETROIT – A vast majority of so-called "super-frequent user" patients who seek care in the Emergency Department (ED) have a substance abuse addiction, according to a Henry Ford Hospital study.
A patient is considered a super-frequent user who visits the ED at least 10 times a year.
ED physicians have long theorized that patients who frequent the ED for their care have a substance abuse addiction. Few studies have actually measured the rate of addiction of these patients.
The study's key findings:
77 percent of patients had a substance abuse addiction.
47 percent ...
Mount Sinai presents important findings at the 2014 American Urological Association Meeting
2014-05-17
(NEW YORK – EMBARGO May 17, 2014) Researchers at the Icahn School of Medicine at Mount Sinai will present several landmark studies at the 2014 American Urological Association (AUA) annual meeting May 17-19, 2014 in Orlando, FL, including data on an immune response in prostate cancer tumors, effects of paternal age on stimulated insemination live birth rates, issues of sexual function after cystectomy and a comparison of modalities for the treatment of benign prostatic hyperplasia (BPH).
Meeting attendees will be able to view a live 3-dimensional video feed of a robotic ...
RELAX-AHF: Poor diuretic response associated with worse clinical outcomes
2014-05-17
Athens, 17 May 2014: Poor diuretic response is associated with worse in-hospital and post-discharge clinical outcomes, results of the RELAX-AHF trial reveal. The study also found that serelaxin has a neutral effect on diuretic response.
These novel data from the RELAX-AHF trial were presented by lead author Professor Adriaan A. Voors at the Heart Failure Congress 2014, held 17-20 May in Athens, Greece. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology.
RELAX-AHF was a double blind, placebo-controlled trial ...
RELAX-AHF and PROTECT studies find targeting WHF may reduce readmissions and save lives
2014-05-17
Athens, 17 May 2014: Worsening symptoms and signs of heart failure (WHF) in patients admitted to a hospital is a common sign of treatment failure and can lead to long-term consequences for the patient, including longer length of hospitalization and a higher risk for readmission and death, according to a late-breaking study (RELAX-AHF, PROTECT) presented in Athens at the ESC's Heart Failure Congress 2014
Heart failure is the most common reason for admission to hospital in people over 65 years old and affects millions of people each year. Research has shown that the outcomes ...
Negative iron balance predicts acute heart failure survival
2014-05-17
Athens, 17 May 2014: Negative iron balance predicts survival in patients with acute heart failure, according to research presented for the first time today at the Heart Failure Congress 2014 in Athens, Greece. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology.
Professor Ewa Jankowska, first author of the study, said: "Patients with acute heart failure have a major collapse in homeostasis. Iron is a key micronutrient that is required for the maintenance of homeostasis. Iron is needed for cellular metabolism ...
Biomarker test for Peripartum Cardiomyopathy could help reduce death after giving birth
2014-05-17
Athens, 17 May 2014: Cardiologists have discovered biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM), a life-threatening disorder that is the primary cause of mortality in pregnant women in developing countries. The results, which can lead to the immediate treatment of PPCM in new mothers and a significant reduction in mortality, were presented at Heart Failure 2014, which opened the World Congress on Acute Heart Failure in Athens the 17 to the 20 May.
"For pregnant women there are two major causes of death: massive hemorrhage ...